Potential Drug-Drug Interaction (PDDI) CDS IG : STU1 Ballot 2
1.0.0-ballot - STU Ballot International flag

Potential Drug-Drug Interaction (PDDI) CDS IG : STU1 Ballot 2, published by HL7 Clinical Decision Support Workgroup. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions

ValueSet: valueset-cyclosporine-exclude (Experimental)

Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude Version: 1.0.0-ballot
Draft as of 2018-07-02 Computable Name: Valueset_cyclosporine_exclude

Copyright/Legal: (copyright expectations unknown)

ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations.

To refine valueset for Digoxin + Cyclosporine PDDI-CDS


This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

  • Include these codes as defined in http://www.nlm.nih.gov/research/umls/rxnorm
    1093178Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]
    402092Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]
    1093177Cyclosporine Ophthalmic Ointment [Optimmune]
    402330Cyclosporine Ophthalmic Suspension [Restasis]
    1093174Cyclosporine 0.002 MG/MG Ophthalmic Ointment
    351291Cyclosporine 0.5 MG/ML Ophthalmic Suspension
    1093173Cyclosporine Ophthalmic Ointment
    378766Cyclosporine Ophthalmic Suspension
    1156187Cyclosporine Ophthalmic Product
    1182342Optimmune Ophthalmic Product
    1182527Restasis Ophthalmic Product



Expansion based on codesystem RxNorm version ??rx1

This value set contains 11 concepts.

  1093178http://www.nlm.nih.gov/research/umls/rxnormcyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]
  402092http://www.nlm.nih.gov/research/umls/rxnormcyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]
  1093177http://www.nlm.nih.gov/research/umls/rxnormcyclosporine Ophthalmic Ointment [Optimmune]
  402330http://www.nlm.nih.gov/research/umls/rxnormcyclosporine Ophthalmic Suspension [Restasis]
  1093174http://www.nlm.nih.gov/research/umls/rxnormcyclosporine 0.002 MG/MG Ophthalmic Ointment
  351291http://www.nlm.nih.gov/research/umls/rxnormcyclosporine 0.5 MG/ML Ophthalmic Suspension
  1093173http://www.nlm.nih.gov/research/umls/rxnormcyclosporine Ophthalmic Ointment
  378766http://www.nlm.nih.gov/research/umls/rxnormcyclosporine Ophthalmic Suspension
  1156187http://www.nlm.nih.gov/research/umls/rxnormcyclosporine Ophthalmic Product
  1182342http://www.nlm.nih.gov/research/umls/rxnormOptimmune Ophthalmic Product
  1182527http://www.nlm.nih.gov/research/umls/rxnormRestasis Ophthalmic Product

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code